MENU
TRLV
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Trulieve Cannabis (TRLV) Earnings Date & Reports

A.I. Advisor
published Earnings

TRLV is expected to report earnings to rise 500.00% to 5 cents per share on August 12

Trulieve Cannabis TRLV Stock Earnings Reports
Q2'26
Est.
$0.06
Q1'26
Beat
by $0.07
The last earnings report on May 07 showed earnings per share of 0 cents, beating the estimate of -5 cents. With 3.22M shares outstanding, the current market capitalization sits at 1.94B.

Trulieve Cannabis Corp. (TRLV) Earnings Preview: Q2 Results in Focus

Key Takeaways

  • Trulieve Cannabis Corp. is scheduled to report second-quarter 2026 results in early August.
  • Analysts project Q2 revenue of approximately $277 million.
  • Consensus EPS estimate stands at $0.08 for the quarter.
  • Investors will monitor gross margins, retail sales contribution, and cash flow generation.
  • Q1 2026 results showed revenue of $287 million and a return to positive net income.
  • Historical stock reactions to earnings have varied based on margin trends and guidance updates.

Earnings Context and Why It Matters

Trulieve Cannabis Corp. operates as a vertically integrated cannabis company focused on cultivation, processing, and retail distribution of medical and adult-use products across multiple U.S. states. The upcoming Q2 2026 earnings report will provide the first update since the company delivered positive net income in Q1 2026. Investors closely watch these results for insights into revenue stability, margin expansion, and operational efficiency in a competitive industry environment. Strong performance in prior quarters has highlighted improving cash flow generation, making this report a key indicator of sustained momentum.

Earnings Expectations

Analyst consensus points to Q2 2026 revenue of about $277 million. The EPS estimate averages $0.08. These figures follow Q1 2026 results of $287 million in revenue and EPS of $0.01, which exceeded the prior consensus of -$0.06. Key metrics under scrutiny include gross margin percentage, the share of revenue from retail sales, adjusted EBITDA, and free cash flow. The company has historically provided updates on same-store sales trends and expansion activities. Past earnings releases have influenced stock volatility depending on whether results aligned with or surpassed expectations for profitability and operational leverage.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. AI Screener

Market Reaction and Investor Sentiment

Sentiment heading into the Q2 report reflects cautious optimism following the profitable Q1 outcome. Market participants are focused on whether revenue growth and margin trends can continue amid evolving state-level regulations and competitive pressures. Historical post-earnings moves have depended on the magnitude of any beats or misses in key profitability metrics and forward commentary. Broader sector sentiment in cannabis stocks may also influence trading around the release.

Forward Outlook and Key Factors to Monitor

Following the earnings release, investors will examine any updates to full-year expectations and comments on demand trends across key markets. Guidance on gross margins and operating expenses will offer clues about cost management. Attention will also turn to cash flow metrics, including free cash flow generation, which supported balance sheet strength in recent periods.

Additional areas of focus include retail sales contribution and potential impacts from new product launches or market expansions. Industry dynamics such as regulatory developments in adult-use states and competition from other operators remain relevant. Monitoring these elements will help assess the company’s trajectory beyond the immediate quarter.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
TRLV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Details